APA (7th ed.) Citation

FJ, M., FM, M., HX, W., & XF, C. (2025). Retraction Note: MiR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3. European review for medical and pharmacological sciences, 29(10), 453. https://doi.org/10.26355/eurrev_202510_37459

Chicago Style (17th ed.) Citation

FJ, Meng, Meng FM, Wu HX, and Cao XF. "Retraction Note: MiR-564 Inhibited Metastasis and Proliferation of Prostate Cancer by Targeting MLLT3." European Review for Medical and Pharmacological Sciences 29, no. 10 (2025): 453. https://doi.org/10.26355/eurrev_202510_37459.

MLA (9th ed.) Citation

FJ, Meng, et al. "Retraction Note: MiR-564 Inhibited Metastasis and Proliferation of Prostate Cancer by Targeting MLLT3." European Review for Medical and Pharmacological Sciences, vol. 29, no. 10, 2025, p. 453, https://doi.org/10.26355/eurrev_202510_37459.